J. Goldman & CO LP Athira Pharma, Inc. Transaction History

J. Goldman & CO LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.74 - $13.43 $130,013 - $637,253	-47,450 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.96 - $13.51 $544,320 - $820,732	-60,750 Reduced 56.15%	47,450 $641,000
Q4 2021 Feb 14, 2022	BUY	$9.17 - $16.39 $992,194 - $1.77 Million	108,200 New	108,200 $1.41 Million

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $23.4M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.